A novel LPS-inducible CCR3 activator: why so many CCR3 ligands?
Lilly
C M
CM
Combined program in Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. clilly@partners.org
Daugherty
B L
BL
D000818:Animals; D054413:Chemokine CCL11; D018925:Chemokines / Q000096:biosynthesis / Q000145:classification / Q000235:genetics / Q000502:physiology*; D019742:Chemokines, CC / Q000502:physiology; D002630:Chemotactic Factors / Q000494:pharmacology / Q000502:physiology; D002633:Chemotaxis / Q000187:drug effects / Q000502:physiology; D004804:Eosinophils / Q000502:physiology; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000378:metabolism; D007223:Infant; D007249:Inflammation / Q000378:metabolism; D008024:Ligands; D008070:Lipopolysaccharides / Q000494:pharmacology*; D051379:Mice; D018345:Mice, Knockout; D011657:Pulmonary Eosinophilia / Q000378:metabolism; D054397:Receptors, CCR3; D019707:Receptors, Chemokine / Q000378:metabolism*; D013379:Substrate Specificity
C515456:CCL11 protein, human; C515350:CCR3 protein, human; C515457:Ccl11 protein, mouse; C515351:Ccr3 protein, mouse; D054413:Chemokine CCL11; D018925:Chemokines; D019742:Chemokines, CC; D002630:Chemotactic Factors; D008024:Ligands; D008070:Lipopolysaccharides; D054397:Receptors, CCR3; D019707:Receptors, Chemokine